SureTrader Advertisement SureTrader
Home > Boards > US OTC > Biotechs > Amarantus Bioscience Holdings Inc. (AMBS)

Price target of AMBS at $1.25!! All aboard!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
barbershop Member Profile
 
Followed By 61
Posts 9,766
Boards Moderated 0
Alias Born 10/26/09
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/21/2016 4:21:56 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/30/2016 5:40:56 PM
Proxy Soliciting Materials (revised) (prer14a) "Edgar (US Regulatory)" - 3/14/2016 5:30:37 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/7/2016 5:02:44 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/4/2016 5:28:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/24/2016 4:17:16 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/24/2016 4:15:34 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 2/23/2016 6:08:20 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/18/2016 5:09:41 PM
Various Development Advancements for Targeted Treatment Therapies for Rare Diseases & Disorders Lead to Newest Orphan Drug "InvestorsHub NewsWire" - 2/10/2016 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/9/2016 4:32:07 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 2/2/2016 10:36:42 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/29/2016 9:08:11 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/28/2016 4:24:11 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/28/2016 4:22:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/19/2016 4:16:35 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/8/2016 5:20:40 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/4/2016 6:03:24 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 12/29/2015 3:17:09 PM
Pharma Industry Poised For Fast Start in 2016 As U.S. Food & Drug Administration Receives Requests for Newest Orphan Drug "InvestorsHub NewsWire" - 12/29/2015 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/10/2015 4:40:14 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/9/2015 5:21:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/7/2015 4:50:23 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/7/2015 4:43:19 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/4/2015 8:55:01 AM
barbershop   Wednesday, 12/26/12 08:08:01 AM
Re: fouraces post# 26607
Post # of 124663 
Price target of AMBS at $1.25!! All aboard!! Wow. Talk about a positive investor note. Abbot is a huge player. Monster.

By reading this or any of my posts, you are accepting the sole responsibility for your own investment decisions. Never buy any stock based on what is posted above. Due your own DD.
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist